We also conducted a disease-specific survival analysis in GC patients with a high SHMT2 expression (156 cases) and a low SHMT2 expression (175 cases) and found that the patients with a high SHMT2 expression had worse prognoses than those with a low expression. The gene discussed is SHMT2; the disease is gastric cancer.